These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32801686)
1. Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin. Lu Z; Qi L; Lin YR; Sun L; Zhang L; Wang GC; Li JQ; Yu JM Int J Nanomedicine; 2020; 15():5203-5215. PubMed ID: 32801686 [TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302 [TBL] [Abstract][Full Text] [Related]
3. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373 [TBL] [Abstract][Full Text] [Related]
4. Metformin-loaded BSA nanoparticles in cancer therapy: a new perspective for an old antidiabetic drug. Jose P; Sundar K; Anjali CH; Ravindran A Cell Biochem Biophys; 2015 Mar; 71(2):627-36. PubMed ID: 25209744 [TBL] [Abstract][Full Text] [Related]
5. Liver cancer targeting of Doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats. Chang JE; Shim WS; Yang SG; Kwak EY; Chong S; Kim DD; Chung SJ; Shim CK Pharm Res; 2012 Mar; 29(3):795-805. PubMed ID: 21971829 [TBL] [Abstract][Full Text] [Related]
6. Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma. Teran-Saavedra NG; Sarabia-Sainz JA; Silva-Campa E; Burgara-Estrella AJ; Guzmán-Partida AM; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L Molecules; 2019 Apr; 24(7):. PubMed ID: 30970533 [TBL] [Abstract][Full Text] [Related]
7. Hepatoma-Targeted Radionuclide Immune Albumin Nanospheres: (131)I-antiAFPMcAb-GCV-BSA-NPs. Lin M; Huang J; Zhang D; Jiang X; Zhang J; Yu H; Xiao Y; Shi Y; Guo T Anal Cell Pathol (Amst); 2016; 2016():9142198. PubMed ID: 26981334 [TBL] [Abstract][Full Text] [Related]
8. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819 [TBL] [Abstract][Full Text] [Related]
9. Interaction of tebuconazole with bovine serum albumin: determination of the binding mechanism and binding site by spectroscopic methods. Bai J; Sun X; Ma X J Environ Sci Health B; 2020; 55(6):509-516. PubMed ID: 32037956 [TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421 [TBL] [Abstract][Full Text] [Related]
11. A Novel Thermal-driven Self-assembly Method to Prepare Albumin Nanoparticles: Formation Kinetics, Degradation Behavior and Formation Mechanism. Li F; Yeh S; Shi Q; Wang P; Wu H; Xin J AAPS PharmSciTech; 2022 Sep; 23(7):250. PubMed ID: 36071310 [TBL] [Abstract][Full Text] [Related]
12. Explication of bovine serum albumin binding with naphthyl hydroxamic acids using a multispectroscopic and molecular docking approach along with its antioxidant activity. Agrawal R; Siddiqi MK; Thakur Y; Tripathi M; Asatkar AK; Khan RH; Pande R Luminescence; 2019 Sep; 34(6):628-643. PubMed ID: 31190435 [TBL] [Abstract][Full Text] [Related]
13. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery. Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261 [TBL] [Abstract][Full Text] [Related]
14. Study on the interaction of graphene oxide‑silver nanocomposites with bovine serum albumin and the formation of nanoparticle-protein corona. Xu X; Mao X; Wang Y; Li D; Du Z; Wu W; Jiang L; Yang J; Li J Int J Biol Macromol; 2018 Sep; 116():492-501. PubMed ID: 29753014 [TBL] [Abstract][Full Text] [Related]
15. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy. Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the binding interactions between 17α-ethinylestradiol with bovine serum albumin by multispectroscopy. Gu J; Liu L; Zheng S; Yang G; He Q; Huang X; Guo C J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020; 55(9):1131-1140. PubMed ID: 32515655 [TBL] [Abstract][Full Text] [Related]
17. Development and Characterization of Metformin Loaded Pectin Nanoparticles for T2 Diabetes Mellitus. Chinnaiyan SK; Karthikeyan D; Gadela VR Pharm Nanotechnol; 2018; 6(4):253-263. PubMed ID: 30574859 [TBL] [Abstract][Full Text] [Related]
18. Biomolecular interaction study of hydralazine with bovine serum albumin and effect of β-cyclodextrin on binding by fluorescence, 3D, synchronous, CD, and Raman spectroscopic methods. Bolattin MB; Nandibewoor ST; Chimatadar SA J Mol Recognit; 2016 Jul; 29(7):308-17. PubMed ID: 26785703 [TBL] [Abstract][Full Text] [Related]
19. Molecular binding of toxic phenothiazinium derivatives, azures to bovine serum albumin: A comparative spectroscopic, calorimetric, and in silico study. Das S; Islam MM; Jana GC; Patra A; Jha PK; Hossain M J Mol Recognit; 2017 Jul; 30(7):. PubMed ID: 28101950 [TBL] [Abstract][Full Text] [Related]
20. Systematic investigation on the interaction of bovine serum albumin with ZnO nanoparticles using fluorescence spectroscopy. Bhogale A; Patel N; Sarpotdar P; Mariam J; Dongre PM; Miotello A; Kothari DC Colloids Surf B Biointerfaces; 2013 Feb; 102():257-64. PubMed ID: 23010116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]